Albemarle Corporation (NYSE: ALB)

Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride.

Recommendation Rationale – SELL at USD 150.01

• Trading Near Resistance Level: ALB’s share price surpassed its R1 level recommended on 16 December 2025, the 14-day RSI is now around 76.17, trading in overbought territory. Therefore, share price can face resistance at the current levels.
• Softer Revenue Performance: Net sales declined to USD 1,307.8 million in Q3 FY25 from USD 1,354.7 million in Q3 FY24, indicating weaker top-line momentum.
• Elevated Long-Term Obligations: Long-term debt increased to USD 3,181.0 million as of 30 September 2025 from USD 3,118.1 million as of 31 December 2024, reflecting a higher leverage position.
• Business Risk: Across geographically diversified assets, production efficiency and supply chain continuity may be affected by geopolitical developments, logistics constraints, elevated energy costs, or disruptions in raw material availability.

ALB’s Daily Price Chart

Daily Technical Chart, Data Source: REFINITV 

Valuation Methodology: EV/Sales Approach (FY December'26E) (Illustrative)

The stock may trade at a slight discount to peers given YoY decline in Q3 FY25 net sales, ongoing net losses, driven by weaker pricing in the Energy Storage segment amid unfavourable lithium market conditions.

For conducting the valuation, peers Sherwin-Williams Co (NYSE: SHW), DuPont de Nemours Inc (NYSE: DD), and CF Industries Holdings Inc (NYSE: CF) have been considered.

Considering that the stock has surpassed its R1 level, current trading levels, rally in share price movement, and risks associated, the share price can face consolidation at the current levels. Hence, a ‘Sell’ recommendation is given on the stock at the closing market price of USD 150.01, as of 26 December 2025.

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical issues prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is neither an indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 26 December 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided have been achieved and is subject to the factors discussed above.

Note 4: Kalkine reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Note 5: Dividend Yield may vary as per the stock price movement.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.